-->

Our new assays have arrived

New products

We are excited to announce the launch of new products from the combined PerkinElmer-Cisbio reagent portfolio.

Using the HTRF® technology

8 assays to detect FGFR1, 2, 3 and 4, both total and phosphorylated:

3 assays to detect Rb. Rb acts as a tumor suppressor and regulates cell cycle progression:

2 kits to detect both total and phosphorylated SMAD2 protein. Smad2 is a receptor-regulated that mediates the signal of the transforming growth factor (TGF)-beta, and regulates multiple cellular processes, such as cell proliferation, apoptosis, and differentiation:

1 HTRF kit to detect phospho S65 ubiquitin:

Cytokine receptor binding

4 assays to detect interaction between IL12, IL23, IL6 and its receptors. IL12 is strongly linked to autoimmunity. IL23 are linked to Crohn’s Disease and psoriasis. And IL6 is involved in various biological processes, including autoimmune diseases and cancers:

Immune checkpoint inhibitors

1 kit to detect LAG3/MHCII interaction. LAG3/MHCII is a checkpoint inhibitor which generates considerable interest in cancer immunotherapy:

SARS-CoV-2 N is major immunogen predominantly expressed at early stages of viral infection. The SARS-CoV-2 Spike S1 protein is one of two part of the virus Spike protein (S). The S1 subunit is responsible for the the virus interaction with host cells’ transmembrane Angiotensin-converting enzyme 2 receptors (ACE2):

Using the Alpha SureFire® CETSA® technology

For all the Alpha® products, please contact your local representatives or visit www.perkinelmer.com

New products flyer

Get our up-to-date listing of new products and find the related sales part numbers

Download

Flyer new products October 2020